Insider · CIK 0001834161

Eisner Mark

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001834161

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+47.7K sh	—	—	47,675
2026-06-17	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+51K sh	—	—	51,000
2026-02-25	VIRVir Biotechnology, Inc.S Sale	EVP and Chief Medical Officer	SSale	−1,889 sh	$9.82	−$18.5K	154,024
2026-02-24	VIRVir Biotechnology, Inc.S Sale	EVP and Chief Medical Officer	SSale	−1,616 sh	$9.53	−$15.4K	155,913
2026-02-23	VIRVir Biotechnology, Inc.S Sale	EVP and Chief Medical Officer	SSale	−2,089 sh	$7.45	−$15.6K	157,529
2026-02-22	VIRVir Biotechnology, Inc.A Award	EVP and Chief Medical Officer	AAward	+55K sh	—	—	159,618
2026-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+110K sh	—	—	110,000
2026-02-21	ZURAZura Bio Ltd · Share Option (Right to Buy)A Award	Director	AAward	+37.8K sh	—	—	37,812
2025-07-17	VIRVir Biotechnology, Inc.S Sale	EVP and Chief Medical Officer	SSale	−3,586 sh	$5.47	−$19.6K	104,618
2025-07-15	VIRVir Biotechnology, Inc.S Sale	EVP and Chief Medical Officer	SSale	−6,796 sh	$5.47	−$37.2K	108,204
2025-02-22	VIRVir Biotechnology, Inc.A Award	EVP and Chief Medical Officer	AAward	+40K sh	—	—	115,000
2025-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+80K sh	—	—	80,000
2024-07-15	VIRVir Biotechnology, Inc.A Award	EVP and Chief Medical Officer	AAward	+75K sh	—	—	75,000
2024-07-15	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+150K sh	—	—	150,000
2023-09-06	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−1,860 sh	$0.96	−$1,791.366	159,917
2023-09-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−1,085 sh	$1.06	−$1,150.1	161,777
2023-06-07	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−2,042 sh	$17.04	−$34.8K	162,862
2023-06-02	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−1,090 sh	$18.83	−$20.5K	164,904
2023-04-04	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−9,182 sh	$18.78	−$172K	165,994
2023-03-10	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−3,885 sh	$20.20	−$78.5K	181,431
2023-03-10	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−6,255 sh	$20.20	−$126K	175,176
2023-03-08	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−7,363 sh	$21.16	−$156K	165,133
2023-03-08	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+7,732 sh	—	—	172,865
2023-03-08	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+12.5K sh	—	—	185,316
2023-03-02	KYNBKYNTRA BIO, INC.S Sale	EVP, Chief Medical Officer	SSale	−1,187 sh	$21.87	−$26K	172,496
2023-02-21	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+32.5K sh	—	—	173,683
2023-02-21	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+55K sh	—	—	55,000
2022-12-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−1,084 sh	$15.04	−$16.3K	141,183
2022-09-30	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−6,777 sh	$13.01	−$88.2K	142,267
2022-09-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−756 sh	$13.09	−$9,896.04	149,044
2022-06-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−1,141 sh	$9.61	−$11K	149,800
2022-03-31	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−6,442 sh	$12.02	−$77.4K	150,941
2022-03-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−756 sh	$13.62	−$10.3K	157,383
2022-02-14	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+60K sh	—	—	158,139
2022-02-14	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+100K sh	—	—	100,000
2022-01-03	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−7,043 sh	$14.82	−$104K	98,139
2021-12-01	KYNBKYNTRA BIO, INC.F Tax Payment	EVP, Chief Medical Officer	FTax Payment	−4,338 sh	$12.65	−$54.9K	105,182
2021-10-04	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+74.5K sh	—	—	109,520
2021-10-04	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+44.5K sh	—	—	44,520
2020-12-01	KYNBKYNTRA BIO, INC.A Award	EVP, Chief Medical Officer	AAward	+35K sh	—	—	35,000
2020-12-01	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+80K sh	—	—	80,000

Recent filings

Accepted (ET)
Jun 264
Eisner Mark0001193125-26-286434
SEC(opens sec.gov)
Jun 224
Eisner Mark0001834161-26-000008
SEC(opens sec.gov)
Feb 264
Eisner Mark0001628280-26-012394
SEC(opens sec.gov)
Feb 244
Eisner Mark0001628280-26-011329
SEC(opens sec.gov)
Feb 244
Eisner Mark0001834161-26-000006
SEC(opens sec.gov)
Jul 174
Eisner Mark0001628280-25-035269
SEC(opens sec.gov)
Feb 254
Eisner Mark0001628280-25-007699
SEC(opens sec.gov)
Jul 164
Eisner Mark0000950170-24-083951
SEC(opens sec.gov)
Sep 84
Eisner Mark0001209191-23-048809
SEC(opens sec.gov)
Sep 64
Eisner Mark0001209191-23-048555
SEC(opens sec.gov)
Jun 94
Eisner Mark0001209191-23-036054
SEC(opens sec.gov)
Jun 54
Eisner Mark0001209191-23-034288
SEC(opens sec.gov)
Apr 64
Eisner Mark0001209191-23-023592
SEC(opens sec.gov)
Mar 104
Eisner Mark0001209191-23-018063
SEC(opens sec.gov)

Companies

Address

C/O JADE BIOSCIENCES, INC. 221 CRESCENT ST., BLDG. 23, STE. 105

WALTHAM, MA, 02453